Cellect Biotechnology Ltd. (NASDAQ: APOP)
Complementary equity research reports on Cellect Biotechnology Ltd.
Report Type
Publish Date
link
On September 3 2017 Cellect voluntarily delisted its shares from trading on the TASE, and withdrew from the TASE Analysis program.
Hereafter all equity research is governed by an agreement between Frost & Sullivan and the Company and concerns the securities listed on the NASDAQ.
